Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v5-EN
Language French English
Date Updated 2020-02-13 2017-10-10
Drug Identification Number 02171791 02171791
Brand name RATIO-ATENOLOL RATIO-ATENOLOL
Common or Proper name ATENOLOL ATENOLOL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ATENOLOL ATENOLOL
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-02-11 2015-02-11
Estimated end date Unknown
Actual end date 2017-12-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product Discontinued.
Health Canada comments